BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis

BACKGROUND: Airway inflammation in chronic inflammatory lung diseases (e.g. bronchiectasis) is partly mediated by neutrophil-derived serine protease (NSP)/antiprotease imbalance. NSPs are activated during neutrophil myelopoiesis in bone marrow by cathepsin C (CatC; DPP1). CatC is therefore an attrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreideweiss, Stefan, Schänzle, Gerhard, Schnapp, Gisela, Vintonyak, Viktor, Grundl, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499737/
https://www.ncbi.nlm.nih.gov/pubmed/37542002
http://dx.doi.org/10.1007/s00011-023-01774-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499737/
https://www.ncbi.nlm.nih.gov/pubmed/37542002
http://dx.doi.org/10.1007/s00011-023-01774-4

Ejemplares similares